Interactions between growing axons and synaptic basal lamina components direct the formation of neuromuscular junctions during nerve regeneration. Isoforms of laminin containing ␣5 or ␤2 chains are potential basal lamina ligands for these interactions. The nerve terminal receptors are unknown. Here we show that SV2, a synaptic vesicle transmembrane proteoglycan, is complexed with a 900-kDa laminin on synaptosomes from the electric organ synapse that is similar to the neuromuscular junctions. Although two laminins are present on synaptosomes, only the 900-kDa laminin is associated with SV2. Other nerve terminal components are absent from this complex. The 900-kDa laminin contains an ␣5, a ␤1, and a novel ␥ chain. To test whether SV2 directly binds the 900-kDa laminin, we looked for interaction between purified SV2 and laminin-1, a laminin isoform with a similar structure. We find SV2 binds with high affinity to purified laminin-1. Our results suggest that a synaptic vesicle component may act as a laminin receptor on the presynaptic plasma membrane; they also suggest a mechanism for activity-dependent adhesion at the synapse.
Interactions between growing axons and synaptic basal lamina components direct the formation of neuromuscular junctions during nerve regeneration. Isoforms of laminin containing ␣5 or ␤2 chains are potential basal lamina ligands for these interactions. The nerve terminal receptors are unknown. Here we show that SV2, a synaptic vesicle transmembrane proteoglycan, is complexed with a 900-kDa laminin on synaptosomes from the electric organ synapse that is similar to the neuromuscular junctions. Although two laminins are present on synaptosomes, only the 900-kDa laminin is associated with SV2. Other nerve terminal components are absent from this complex. The 900-kDa laminin contains an ␣5, a ␤1, and a novel ␥ chain. To test whether SV2 directly binds the 900-kDa laminin, we looked for interaction between purified SV2 and laminin-1, a laminin isoform with a similar structure. We find SV2 binds with high affinity to purified laminin-1. Our results suggest that a synaptic vesicle component may act as a laminin receptor on the presynaptic plasma membrane; they also suggest a mechanism for activity-dependent adhesion at the synapse.
SV2
1 is a transmembrane keratan sulfate proteoglycan of synaptic vesicles (1, 2) . It exists in two forms, heavy (H) and light (L) , that differ in glycosylation (2) . This proteoglycan has been purified and characterized from the electric organ synapse (1-4) which is structurally and molecularly similar to the vertebrate neuromuscular junction (5, 6 ). In electric organ the H form of SV2 is identified by two monoclonal antibodies (Tor 70 and anti-SV1) that bind to the same unique keratan sulfate epitope (SV1) in the lumen of synaptic vesicles (2, 4, 7) . Both the H and L forms are identified by a monoclonal antibody, anti-SV2, that binds a protein epitope on the cytosolic side of synaptic vesicles (1, 2) . On SDS-PAGE the L form migrates like a protein of about 90 kDa, whereas the H form migrates with the characteristic heterogeneous mobility of a proteoglycan, between 90 and above 200 kDa (2) . Both forms of SV2 appear to be present in vertebrate synapses, including those of electric fish (2) , rat (2) , and human (8) . SV2 is also found in endocrine cells (1) .
The cDNA that encodes the SV2 protein has been cloned from rat (9 -11) , cow (11) , and electric fish (12) . Three different genes coding for SV2 have been found in rat (13, 14) . The inferred amino acid sequence suggests that the protein has 12 transmembrane domains and a distant sequence homology to both bacterial and eukaryotic sugar transporters (9 -11) . As yet, however, no transport activity or any other function has been found for SV2.
SV2 contains a large loop between putative transmembrane domains 7 and 8 with three highly conserved N-linked glycosylation sites (12, 13) . These are the likely locations for the attachment of the keratan sulfate side chains recognized by anti-SV1 mAb (2) . Previously it was shown that the SV1 epitope of SV2 was not only present in synaptic vesicles (4) but on the nerve terminal surface of electric organ synapses as well (15) . Based on this finding, Buckley et al. (15) hypothesized that this synaptic vesicle proteoglycan was retained on the surface of synaptosomes due to interactions with components of the synaptic cleft. In fact, it is known that interactions between the nerve terminal membrane and the extracellular matrix (ECM) of the synaptic cleft are critical for nerve regeneration at the neuromuscular junction. ECM in the synaptic cleft directs the rebuilding of this synapse after nerve injury (16) . The axon distal to the injury degenerates and a new neurite regrows from the cut end to form a new nerve terminal at the original synaptic site. Not only does the regenerating neurite appear to use ECM cues to find the vacated original synaptic site, the sites of neurotransmitter release within the nerve terminal form at their original locations, directed by ECM cues (17, 18) . Presumably, ECM receptors of the nerve terminal recognize synapse-specific ECM components.
Although the nerve terminal ECM receptors involved in nerve regeneration are unknown, the ECM protein laminin is a good candidate for an ECM cue (19) . Laminins are large heterotrimeric glycoproteins with molecular masses of 700 -900 kDa, each containing an ␣, a ␤, and a ␥ chain (20) . Five ␣ chains, three ␤ chains, and three ␥ chains have been described to date (20 -24) . Three chains, ␣5, ␣4, and ␤2, have been specifically localized to the synaptic basal lamina of the neuromuscular junction (25, 26) , although the exact trimeric structures at this synapse have not been elucidated. Mutant mice that lack one of these chains, ␤2, have a pronounced defect in neuromuscular development that includes impaired maturation of nerve terminals (27) and also show defects in reinnervation of muscle following nerve damage (28) .
Here we present evidence that the SV2H on the surface of electric organ nerve terminal may act as a laminin receptor in addition to its function in the synaptic vesicle. On the surface of isolated synaptosomes SV2H is associated with a 900-kDa laminin that is composed of an ␣5, ␤1, and a novel ␥ chain. However, SV2H is not associated with a laminin protein in purified synaptic vesicles. The interaction of terminal-associated SV2H with the 900-kDa laminin is strong in that it resists dissociation by high pH. In addition, purified SV2H binds purified laminin-1. We hypothesize that SV2H can act as a laminin receptor after neurotransmitter release, at which time SV2H is still part of the presynaptic plasma membrane. Because the amount of SV2H on the nerve terminal membrane should be directly related to the level of vesicle exocytosis, the interaction of SV2H and laminin could be highly activity-dependent.
EXPERIMENTAL PROCEDURES
Materials-The elasmobranch electric rays Narcine brasiliensis and Torpedo californica were obtained from Gulf Specimens (Panacea, FL) and Marinus Inc. (Long Beach, CA), respectively. Immunobeads (goat anti-mouse immunoglobulins, heavy and light chain-specific) were purchased from Irvine Scientific (Santa Ana, CA). Sulfo-NHS-Biotin used for protein labeling was purchased from Pierce. Ultrapure mouse laminin-1 (Engelbreth-Holm-Swarm sarcoma laminin, entactin (nidogenfree) was purchased from Collaborative Biomedical Products (catalog number 4023) of Becton Dickinson Labware (Bedford, MA). Anti-mouse laminin-1 was prepared by injection of ultrapure mouse laminin-1 into rabbits. The antibody reacts with all three chains of purified mouse laminin-1 on Western blots. Rabbit antibodies specific for electric fish synaptotagmin or synaptophysin were prepared by immunization of rabbits with the peptide CMKTRETHPQAFVAPMAT or CG-GYSQPVPTSFTNQM, respectively, and then conjugated to keyhole limpet hemocyanin following the methods of Hockfield et al. (29) . Except for the N-terminal cysteine residues, these sequences are present in the N terminus of synaptotagmin or the C terminus of synaptophysin from electric organ synaptic vesicles (30, 31) . The anti-synaptotagmin antibody was used as an IgG fraction that was purified with protein A, as described by Hockfield et al. (29) . The anti-synaptophysin antibody was used as an antiserum. Monoclonal antibodies, anti-SV1 and anti-SV2, are of the IgG1 isotype and were produced as hybridoma supernatants following the procedures of Hockfield et al. (29) . MOPC-21 (an IgG1) and triacetylchitotriose were obtained from Sigma. Anti-laminin ␣5 chain rabbit antisera were made against a fusion protein as described in Miner et al. (22) . It shows no cross-reactivity with the ␣1, ␤1, or ␥1 chains of laminin-1 (22) . The anti-laminin ␥1 mAb (D18) was generated as described by Sanes et al. (25) and was purchased from Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA). Monoclonal antibodies directed against the ␣ subunit of acetylcholine receptor and rapsyn were gifts from Dr. Stanley Froehner (University of North Carolina, Chapel Hill, NC). Affinity-purified antiCa 2ϩ channel (␣1 subunit, residues 1382-1400) antibodies were a gift from Dr. Ruth Westenbroek and Dr. William Catterall (University of Washington, Seattle, WA) and were prepared according to Striessnig et al. (32) . The anti-agrin monoclonal antibody, 11D2, was a gift from Dr. Justin Fallon (Brown University, Providence, RI). The SABC kit for detection of biotinylated protein was purchased from Zymed Laboratories Inc. (San Francisco, CA). Tomato (Lycopersicon esculentum) lectin agarose was obtained from Vector Laboratories (Burlingame, CA).
The affinity co-electrophoresis (ACE) gel apparatus used in these experiments was designed after that made by Lim et al. (33) . SeaPlaque low gelling temperature agarose was purchased from FMC BioProducts (Rockland, ME).
Electric Organ Synaptosomes and Immunoprecipitations of SV2-Synaptosomes were prepared from fresh electric organ tissue (either N. brasiliensis or T. californica) as described by Miljanich et al. (34) and Yeager et al. (35) with differential centrifugation and sedimentation equilibrium. We refer to this preparation as partially purified synaptosomes because it contains postsynaptic membranes as well as synaptosomes.
In some cases we further purified the synaptosomes by immunoisolation using the anti-SV1 mAb and the methods of Buckley et al. (15) . This procedure reduces the relative abundance of acetylcholine receptor-containing membranes (postsynaptic membranes) more than 10-fold (34) , so that acetylcholine receptor cannot be detected by Western blot. 2 Partially purified synaptosomes (300 g of protein) were washed 3 times in 400 mM NaCl, 1% BSA, 20 mM HEPES, pH 7.0 (S-buffer), by centrifugation at 10,000 ϫ g for 10 min followed by resuspension to a volume of 1 ml. This solution is iso-osmotic for fish synaptosomes. Aliquots of anti-SV1 monoclonal antibody (mAb) in a hybridoma supernatant were centrifuged 20 min at 10,000 ϫ g at 4°C to remove any precipitated material and then added to the synaptosome suspension, 1 ml of supernatant per 150 g of synaptosomal protein. This antibodysynaptosome suspension was incubated with gentle mixing overnight at 4°C. Membranes were washed 3 times in S-buffer, centrifuged 10 min at 10,000 ϫ g at 4°C, and resuspended in 1 ml of S-buffer. This mixture was then layered on 2 ml of 12% Ficoll in S-buffer and centrifuged 5 min at 2,000 ϫ g. The top 2 ml of this solution was withdrawn and mixed with polyacrylamide beads to which goat anti-mouse Ig antibodies were covalently attached (immunobeads). These immunobeads were washed in S-buffer and resuspended to form a 10% slurry. The bead slurry was added to the antibody-labeled membranes, 100 l of 10% slurry, 150 g of synaptosomal protein, and the solution was gently mixed overnight at 4°C. After incubation the bead solution was layered on 2 ml of 12% Ficoll and pelleted by centrifugation at 2,000 ϫ g for 5 min. The pellet was washed 2 times in S-buffer without BSA and prepared for SDS-PAGE (36) . Control precipitations were conducted by substituting a commercially obtained IgG1 mAb (MOPC-21) for anti-SV1 monoclonal antibody in the initial incubation.
To immunoprecipitate Triton X-100-solubilized SV2 from the synaptosomal surface with anti-SV1 mAb, partially purified synaptosomes were incubated with anti-SV1 or MOPC-21 and washed as described for the immunoprecipitation of synaptosomes. The washed synaptosomes were solubilized in 1 ml of S-buffer containing 1.5% Triton X-100. The solution was layered on 12% Ficoll also containing 1.5% Triton X-100 and the immunoprecipitation proceeded as described above for intact synaptosomes with goat anti-mouse Ig immunobeads. All solutions contained S-buffer with 1.5% Triton X-100. In addition to immunoprecipitating the Triton X-100-solubilized SV2⅐900-kDa complex with anti-SV1, we used the anti-SV2 mAb as well. The procedure was the same as used for anti-SV1, except for the use of alkaline-stripped synaptosomes (see below).
Preparation and Analysis of Alkaline-stripped Synaptosomes-To test the strength of the interactions between proteins in partially purified synaptosome preparation, we alkaline-stripped these synaptosomes by exposure to solutions of pH 11.5. Such conditions can strip peripheral membrane proteins from their parent membranes (37) . Partially purified synaptosomes (1.5 mg) were resuspended in 1 ml of SW-buffer (S-buffer without 1% BSA), spun down by centrifugation at 10,000 ϫ g for 10 min at 4°C, and the supernatant discarded. This was repeated once more with SW-buffer and then once with 400 mM NaCl. The synaptosomes were resuspended in 800 l of 400 mM NaCl, divided into 2 aliquots of equal volume, and pelleted by centrifugation at 10,000 ϫ g, 10 min, 4°C. One pellet was resuspended in 100 l of 100 mM CAPS, 300 mM NaCl, pH 11.5, and the other with 100 l of 100 mM HEPES, 300 mM NaCl, pH 7.5. Each aliquot was incubated at 4°C for 30 min with gentle agitation. The synaptosomes were pelleted as described above, the supernatant discarded, and the pellet resuspended in 400 l 100 mM HEPES, 300 mM NaCl, pH 7.5. The synaptosomes were incubated at 4°C for 30 min with gentle agitation and then pelleted by centrifugation. These pelleted synaptosomes were washed twice with SW-buffer by resuspension and centrifugation. The resulting pelleted synaptosomes were solubilized with SDS-containing final sample buffer for SDS-PAGE.
To label the proteins on the surface of alkaline-stripped synaptosomes, we used biotinylation. All procedures were done at 4°C. Partially purified synaptosomes (1.3 mg of synaptosomal protein) were alkaline-stripped (see above). These membranes were washed three times by resuspension in 1 ml of biotinylation buffer (400 mM NaCl, 30 mM HEPES, pH 8.5) and centrifugation at 10,000 ϫ g for 10 min. The alkaline-stripped synaptosomes were resuspended in 1 ml of biotinylation buffer, and 190 l of Sulfo-NHS-Biotin (50 mg/ml in Me 2 SO) was added. The reaction was allowed to proceed for 2 h with gentle agitation to ensure that the membranes remained in suspension. The synapto-somes were washed three times with 1 ml of 400 mM NaCl, 20 mM HEPES, pH 7.0.
Synaptic Vesicles and Immunoprecipitations of SV2-Synaptic vesicles were purified from electric organ by the methods of Carlson et al. (38) . To immunoprecipitate SV2 from synaptic vesicles with anti-SV2 or SV1 mAbs the procedures of Scranton et al. (2) were used. Briefly, 25 g of purified electric organ synaptic vesicles were solubilized in 250 l of 0.28 M NaCl, 20 mM HEPES, pH 7.4, 0.1% BSA, and 1.5% Triton X-100. A 10% slurry of goat anti-mouse Ig immunobeads (75 l) to which the anti-SV1, anti-SV2, or a control mAb (MOPC-21) had been previously bound (as described in Ref. 39 ) was added to the solubilized vesicles. The mixture was incubated overnight at 4°C with gentle agitation. The immunobeads were then separated from the vesicle solution by centrifugation at 10,000 ϫ g for 10 min at 4°C, and the immunobeads were washed as described above for synaptosomes.
Purification and Iodination of SV2-SV2 was immunopurified on Affi-Gel matrix to which the anti-SV2 mAb had been covalently attached. The anti-SV2 mAb was purified with protein A from ascites fluid following the methods of Hockfield et al. (29) . Affi-Gel-10 was washed with 10 ml of a MOPS buffer (100 mM NaCl, 50 mM MOPS, pH 6.8). Purified anti-SV2 (25 mg in 2 ml of MOPS buffer) was mixed with 1.4 ml of Affi-Gel, and the resulting suspension was gently mixed overnight at 4°C. The Affi-Gel was then pelleted at 6,000 rpm, and the supernatant was withdrawn to assay remaining protein. The Affi-Gel was then washed three times in MOPS buffer, once in basic CAPS buffer (100 mM CAPS, pH 11.5), and three additional times in MOPS buffer. The coupling efficiency of this reaction was determined to be 98.3%. One ml of this Affi-Gel was placed in a 10-ml column and equilibrated with column buffer (0.2 M NaCl, 10 mM MOPS, 1% Triton X-100, pH 7.5).
To purify SV2, we used the following procedures: synaptic vesicles were isolated from 300 g of electric organ with the methods of Carlson et al. (38) , but the CPG-3000 column step was omitted. These synaptic vesicles were diluted 2 times with 400 mM NaCl, 10 mM HEPES, 10 mM EGTA, pH 7.0, and pelleted by centrifugation at 158,000 ϫ g for 10 h at 4°C in a Beckman 45Ti rotor. The pellet was solubilized with 3 ml of 0.2 M NaCl, 10 mM MOPS, 2% Triton X-100, pH 7.5, and the solubilized vesicle proteins centrifuged at 4°C for 15 min in an Eppendorf centrifuge. The supernatant was collected and applied to the Affi-Gel anti-SV2 mAb column. The column was washed with 20 ml of column buffer and then eluted with 10 ml of 100 mM CAPS, pH 11.5, where 1-ml fractions were collected. Each fraction was neutralized with 130 ml of 1 M HEPES, pH 7.0, and assayed for SV2 antigenicity by dot blots (4). Recovery of SV2 antigen eluted form the column was usually about 40%.
We labeled purified SV2 with 125 I-diazotized iodosulfanilic acid as described by Scranton et al. (2) . The labeled H form of SV2 was isolated by affinity chromatography on a tomato (Lycopersicon esculentum) lectin-agarose column. About 1 g of 125 I-labeled SV2 was applied to a 0.5-ml column of tomato lectin-agarose equilibrated with 150 mM NaCl, 0.1 mM Ca 2ϩ acetate, 0.5% CHAPS, 10 mM HEPES, pH 7.0. (This buffer solution was used throughout the chromatography.) The L form of SV2 passed through the column without binding. After extensive washing of the column, the bound 125 I-SV2H was eluted with 2 ml of 0.5 mg/ml triacetylchitotriose.
To isolate the L form of SV2 free of unbound 125 I, we used the sedimentation velocity centrifugation on 5-20% sucrose gradients. The 125 I-SV2L, which passed through the tomato lectin column without binding, was concentrated with a Centricon-30 (Amicon, Danvers, MA) and layered on a 5-25% sucrose gradient containing 400 mM NaCl, 1.5% Triton X-100, 20 mM HEPES, pH 7.0. The gradients were centrifuged for 6 h at 300,000 ϫ g, 4°C in an SW-55 rotor, and fractions were collected. Aliquots of each fraction were subjected to SDS-PAGE and autoradiography to locate the 125 I-SV2L in the gradient. For immunoprecipitations of 125 I-SV2 with anti-SV1 or anti-SV2 mAbs, we used the methods of Scranton et al. (2) , which do not involve denaturing conditions. Here, the mAbs (anti-SV1, anti-SV2, or MOPC-21) were bound to immunobeads before the immunobeads were added to the antigen. Forty microliters of a 10% immunobead slurry were used in a total reaction volume of 340 l.
ACE-In order to determine the strength of the interaction between SV2H and laminin, ACE was performed according to the methods of Lee and Lander (40) . Briefly, a 75 ϫ 100 plexiglass tray was fitted with GelBond, and the sides were taped. A lane-forming comb and slotforming comb were added, and then a 1% agarose gel was poured (1% low-gelling temperature agarose in ACE gel buffer, 1% CHAPS, 50 mM MOPS, 1 mM EDTA, 125 mM sodium acetate, pH 7.2). The gel was allowed to solidify, and the slot-forming comb was removed. Serial dilutions of laminin-1 (1:2 dilutions, starting at about 360 nM laminin) were made in 350 l of ACE gel buffer. Each dilution was mixed with a 2% agarose solution in ACE gel buffer (heated to 42°C) and immediately placed in the slots. The agarose in the slots was allowed to solidify, and the entire ACE gel was placed in a water-cooled horizontal gel apparatus. ACE running buffer (50 mM MOPS, 125 mM sodium acetate, pH 7.2) was added until the gel was well submerged. An aliquot of purified 125 I-SV2H was mixed with 10ϫ ACE gel buffer and H 2 O to give a final concentration of 1ϫ ACE gel buffer. In addition, glycerol was added to a final concentration of 10%, and 3 l each of 0.1% bromphenol blue and phenol red were added. The final sample volume was 120 l. The sample comb was removed and the diluted 125 I-SV2H added to the gel. ACE was performed at 300 mA for 4 h, until the phenol red reached the end of the dilution lanes. The gel was then removed from the apparatus, dried, and exposed to x-ray film for autoradiography.
In order to determine the exact concentration of laminin-1 for ACE, an aliquot of this protein was hydrolyzed with constant boiling HCl, and the hydrolysate was subjected to amino acid analysis (AAA Laboratory, Mercer Island, WA). Visualization by silver stain of laminin-1 on an SDS-polyacrylamide gel indicated that the protein was 98.8% pure and entactin (nidogen-free) as stated by the manufacturer (Collaborative Biomedical Products of Becton Dickinson Labware, Bedford, MA). The molecular mass of the protein was taken to be 900 kDa (41). (36) . Antigen was eluted from immunobeads for SDS-PAGE by boiling the beads in the final sample buffer of Laemmli (36) . All SDS-PAGE that was performed under reducing conditions utilized 2.7% acrylamide stacking gels with 2.7-14% acrylamide gradient resolving gels. For SDS-PAGE performed under nonreducing conditions, we used 2.7% stacking gels with 3-9%, 3-7%, or 3-5% resolving gels. For molecular weight standards we used Rainbow TM protein molecular weight markers from Amersham Pharmacia Biotech and mouse laminin-1 purified from EHS tumors (Becton Dickinson Labware, Bedford, MA). For laminin-1 the ␣1 chain has a molecular mass of 440 kDa, the ␤1 chain 230 kDa, and ␥1 chain 220 kDa (42) .
SDS-PAGE and Nitrocellulose Blotting Procedures-SDS-PAGE was performed according to Laemmli
Nitrocellulose blotting procedures were performed as described previously (2) except that the transfer buffer contained 0.1% SDS, and the transfer time was 3 h. Biotinylated proteins bound to nitrocellulose were detected by streptavidin with the SABC kit following the manufacturer's instructions. Horseradish peroxidase-conjugated antibody or horseradish peroxidase-streptavidin bound to blots were visualized with x-ray film and a luminol detection system (ECL from Amersham Pharmacia Biotech). Sometimes we reprobed blots a second time. By using an antibody, we reprobed a blot that had been originally probed for biotinylated proteins. Similarly, we reprobed with a rabbit polyclonal antibody a blot that had originally been exposed to a mouse monoclonal antibody. To visualize the second probe, we inactivated the horseradish peroxidase bound to the blot by exposure overnight at room temperature to an aqueous solution of 0.02% sodium azide. We never found the horseradish peroxidase from the first probe to be visualized on x-ray film in the second luminol reaction. (15) demonstrated that SV2H is present on the surface of electric organ nerve terminals both by immunoelectron microscopy and the immunoprecipitation of synaptosomes (reviewed in Ref. 43 ). These workers hypothesized that this proteoglycan is complexed on the surface of the nerve terminal with synaptic cleft components (15) . Here, we tested this hypothesis by characterizing detergent-solubilized SV2 immunoprecipitated from the surface of synaptosomes. For this purpose we used the anti-SV1 mAb, because the SV1 epitope is present on the extracellular domain of SV2 (2). Anti-SV1 mAbs were first bound to the surface of synaptosomes; the excess mAbs were washed away, and then the synaptosomes were solubilized with detergent, Triton X-100. The detergentsolubilized SV2⅐mAbs complexes were immunoprecipitated with polyacrylamide beads coated with goat anti-mouse IgG antibodies (immunobeads). As expected, the immunoprecipitated material was recognized by both anti-SV2 and anti-SV1 mAbs (Fig. 1A, lanes 1 and 3, respectively) . A control IgG1 mAb immunoprecipitated no SV2 from the synaptosomes (Fig. 1A,  lanes 2 and 4) . SV1-reactive SV2 migrated as a broad band characteristic of the H form (2) and typical of some proteoglycans (e.g. Ref. 44) due to the heterogeneity of the glycosaminoglycan side chains. Since the anti-SV1 mAbs were used to immunoprecipitate SV2, only the H form of SV2 is immunoprecipitated and not the L form.
RESULTS

An SV2H⅐Laminin Complex on the Surface of Electric Organ Synaptosomes-Buckley et al.
We then asked whether SV2H immunoprecipitated from the synaptosomal surface was associated with laminin, a major component of synaptic basal lamina. Initially, we used an antiserum to laminin-1 that recognizes the ␣1, ␤1, and ␥1 chains of mammalian laminin. By using Western blots following SDS-PAGE under reducing conditions, we observed a co-immunoprecipitating immunoreactive protein (Fig. 1A , lane 5, lower) migrating about 230 kDa (228 Ϯ 7 (S.D.)). The size of this protein is similar to that expected for a ␤ or ␥ chain (20) . When the SDS-PAGE was performed under non-reducing conditions to preserve the disulfide linkages between the 3 laminin subunits, the laminin migrated at about 900 kDa (Fig. 1A, lane 5, upper) . This mobility is almost identical to that of the mammalian laminin heterotrimers that contain ␣1, ␣2, or ␣5 chains (22) .
In addition to the anti-SV1 mAb, the solubilized SV2⅐900-kDa laminin complex can be immunoprecipitated with the anti-SV2 mAb that binds a cytosolic domain on SV2. To determine this, we first lysed synaptosomes with a pH 11.5 buffer, which does not dissociate the 900-kDa⅐laminin complex (see below). This treatment generates synaptosomes in which the SV2 epitope is exposed. These synaptosomes were incubated with the anti-SV2 mAb, solubilized by Triton X-100, and immunoprecipitated with immunobeads as described for anti-SV1. Western blots show that the 900-kDa laminin was specifically immunoprecipitated by the anti-SV2 mAb (Fig. 1C, lane 1) .
SV2H in Synaptic Vesicles Is Not Associated with LamininPurified electric organ synaptic vesicles were solubilized with detergent, and the solubilized SV2 was immunoprecipitated with anti-SV1 (Fig. 1B, lane 1) , anti-SV2 (Fig. 1B, lane 2) , or a control mAb (Fig. 1B, lane 3) . The resulting immunoprecipitates were subjected to SDS-PAGE under reducing conditions, and Western blots were probed with either anti-SV2 (Fig. 1B,  lanes 1-3, upper) or anti-laminin-1 antibodies (Fig. 1B, lanes  1-3, lower) . Unlike SV2 immunoprecipitated from the surface of synaptosomes, these Western blots probed with anti-laminin 1 reveal no 230-kDa laminin chain (Fig. 1C, lanes 1 and 2,  lower) . Moreover, lysate of purified synaptic vesicles contained no detectable laminin (data not shown). Thus, although laminin is associated with the SV2H on the nerve terminal surface, it is not present and not associated with this proteoglycan in electric organ synaptic vesicles.
Other Presynaptic Proteins Are Excluded from the SV2⅐900-kDa Laminin Complex-To ask whether the SV2⅐900-kDa laminin complex is a general aggregate of presynaptic proteins, we tested the immunoprecipitated complex for the presence of the ␣1 subunit of the calcium channel, a presynaptic plasma membrane protein (19, 45) , and synaptotagmin, a synaptic vesicle protein (19, 31) . First, we confirmed that these proteins were present in intact immunopurified synaptosomes, using the procedures of Miljanich et al. (34) and Buckley et al. (15) . This immunopurification method employs the anti-SV1 mAb to bind intact synaptosomes to immunobeads. The resulting preparation is enriched for nerve terminal components and contains at least 10 times less postsynaptic (acetylcholine receptor-containing) membranes (34) . In fact, we are unable to detect acetylcholine receptor in these membranes by Western blotting methods. 2 With these synaptosomes we find that both ␣1 subunit of the calcium channel ( Fig. 2A, middle, lane 1, arrow) and two isoforms of synaptotagmin (31) are present ( Fig. 2A, lower,  lane 1, arrows) . However, unlike the 900-kDa laminin ( Fig. 2A,  upper, lane 3) neither protein is specifically co-immunoprecipitated with solubilized SV2H (Fig. 2A, middle and lower, lanes  3) . A very small amount of the 740-kDa laminin and Ca ϩ2 channel is detected in both anti-SV2 mAb (lane 3) and control mAb (lane 4) due to nonspecific adsorption by immunobeads.
Since SV2H is associated with a laminin on the surface of synaptosomes, we wished to determine how many laminins were present. By using the anti-SV1 mAb, we immunoprecipitated intact electric organ synaptosomes and subjected these membranes to Western blots probed with anti-laminin-1 antibodies. With non-reducing SDS-PAGE two laminins are detected with mobilities of 900 kDa ( Fig. 2A, upper, lane 1, arrow) and 740 kDa ( Fig. 2A, upper, lane 1 arrowhead) , respectively. This immunoprecipitation is specific: mock immunoprecipitation of synaptosomes with control mAb yields no 900 kDa and only a very small amount (Ͻ5% of that in lane 1) of 740 kDa 1, 3, and 5 ) or control mAb (lane 2, 4, and 6) were used to immunoprecipitate Triton X-100-solubilized SV2H from the surface of synaptosomes. Western blots of the immunoprecipitates were probed with anti-SV2 mAb (lanes 1 and 2) , anti-SV1 mAb (lanes 3 and 4) , or anti-laminin-1 antibody (lanes 5 and 6, upper and lower) . SDS-PAGE was performed under reducing (lanes 1-4, 5 and 6, lower) or non-reducing conditions ( lanes 5 and 6, upper) . B, SV2 was immunoprecipitated from Triton X-100-solubilized and purified synaptic vesicles with anti-SV1 (lane 1), or anti-SV2 (lane 2), or control mAb (lane 3). Western blots of these antigen-antibody conjugates were probed with either anti-SV2 (upper) or anti-laminin-1 antibodies (lower). In lane 2, the H form and L form (at about 90 kDa) are not resolved from one another. SDS-PAGE was performed under reducing conditions. C, the 900-kDa laminin and SV2 are co-immunoprecipitated from Triton X-100-solubilized synaptosomes with the anti-SV2 mAb (lane 1) but not with a control mAb (lane 2). The Western blots were probed with anti-laminin-1, and SDS-PAGE was performed under non-reducing conditions. Molecular mass markers are shown at the right of the lanes and are expressed in kDa. Laminin-1 was used to determine the mobility of a 900-kDa protein on SDS-PAGE. Abbreviations used are as follows: Ln 1, anti-laminin-1 Abs; Ctl, control mAb; IP, immunoprecipitation; Blot, Western blot.
SV2⅐Laminin Complex (Fig. 2, upper, lane 2) . Thus, not only do synaptosomes contain the 900-kDa laminin but also a 740-kDa laminin. However, as shown above (Fig. 1A, lane 5, upper) and reconfirmed here (Fig.  2, upper, lane 3) , only the 900-kDa laminin co-immunoprecipitates with SV2H solubilized from the synaptosomal surface.
The synaptic basal laminin protein agrin does not co-immunoprecipitate with the SV2H⅐laminin complex although we can detect agrin in immunoprecipitated synaptosomes (data not shown). Thus, even within the basal lamina, SV2 interacts selectively with a subset of components.
Subunit Composition of SV2H-associated Laminin-The size of the co-immunoprecipitating 900-kDa laminin suggested that its ␣ chain must be large, approximately 400 kDa, probably an ␣1, ␣2, or ␣5, and not the smaller ␣3 or ␣4 chains (22) . Indeed, we found that this laminin was stained with an anti-␣5 antibody on Western blots (Fig. 2B upper, lane 1, arrow) . In addition, the presence of a 230-kDa chain that cross-reacts with an anti-laminin-1 antibody suggested that this laminin contains either a ␤1 or ␥1 chain. Moreover, we were unable to stain the laminin with a mouse monoclonal antibody directed against the ␥1 chain (Fig. 2B lower lane 1, arrow) , even though this antibody reacts with the 740-kDa laminin on electric organ synaptosomes (data not shown). Thus, the 230-kDa chain that is stained by the anti-laminin-1 antibody is most likely a ␤1 chain and not a ␥1 chain. However, it is still possible that the lack of reactivity of the 900-kDa laminin with the anti-␥1 mAb could be due to epitope masking or removal of the epitope from the ␥1 chain by alternative slicing. As yet we have not identified the ␥ chain in the 900-kDa laminin. Finally, the 900-kDa laminin shows no immunoreactivity with anti-␤2 laminin antibodies, whereas the 740-kDa laminin is reactive. 2 The SV2⅐Laminin Complex Is Resistant to Dissociation by pH 11.5-Many protein-protein interactions are broken by high pH. For example, solutions of pH 11.5 are commonly employed to elute antigens from antibody affinity columns (29) . This high pH can also strip peripheral membrane proteins from their membranes, such as rapsyn from acetylcholine receptor-rich membranes (37) . However, interactions between matrix proteins can require stronger conditions for solubilization (e.g. Ref. 46) . To determine whether the interaction between SV2H and laminin was of this latter category, we exposed partially purified synaptosomes to solutions of either pH 11.5 or pH 7.4 at 4°C for 30 min. The membranes were pelleted by centrifugation at 10,000 ϫ g for 10 min. These conditions should sediment synaptosomes and presynaptic plasma membranes but not membranes the size of synaptic vesicles. The pelleted membranes were then subjected to Western blot or processed for immunoprecipitation of the Triton X-100-solubilized SV2⅐900-kDa laminin complex. Since the partially purified synaptosomal preparations contained postsynaptic membranes as well as synaptosomes, we checked the effectiveness of our treatment by looking at whether rapsyn was removed from acetylcholine receptor. Alkaline pH clearly stripped rapsyn (Fig. 3A , rapsyn, lane 2) from acetylcholine receptor (Fig. 3A, AchR, lane 2) , whereas neutral pH was without effect (Fig. 3A, rapsyn and AchR, lane 1). The amount of rapsyn decreased ϳ6-fold after high pH treatment. In addition, the pH 11.5 solution lysed synaptosomes and removed synaptic vesicles. The amount of the synaptic vesicle protein synaptophysin in synaptosomes is decreased by the alkaline pH treatment (Fig. 3A, p38 , compare lane 1 with lane 2). Presumably the synaptophysin that remains associated with synaptosomes represents either tightly docked synaptic vesicles or synaptic vesicle membrane that has undergone exocytosis.
In contrast, exposure of synaptosomes to pH 11.5 did not dissociate laminin from SV2H. The same amount of 900-kDa laminin was isolated from synaptosomes by immunoprecipitation of Triton X-100-solubilized SV2, whether or not the membranes were exposed to pH 11.5 (Fig. 3B, compare lanes 2c with  1a) . Thus, the interaction between this extracellular matrix protein and SV2H is stronger than that between the intracellular peripheral membrane rapsyn and acetylcholine receptor. 3 and 4, respectively, Ln 1) . Lower, SV2H was immunoprecipitated from solubilized synaptosomes as described for lanes 3 and 4 in A, and the resulting Western blot probed first with an anti-␥1 mouse monoclonal antibody (lanes 1 and 2, respectively, ␥1), and then the same blot was reprobed with anti-laminin-1 rabbit antibody (lanes 3 and 4, respectively, Ln 1) . SDS-PAGE was performed under non-reducing conditions for A, upper, and B, and reducing conditions for A, middle and upper. FIG. 3 . Strength of the association of SV2H with the 900-kDa laminin. Partially purified synaptosomes that contain both pre-and postsynaptic membranes were exposed to solutions of either pH 7.4 (lanes 1) or pH 11.5 (lanes 2). A, Western blots of these treated pH synaptosomes were probed with antibodies directed against AchR, rapsyn, and synaptophysin (p38). B, solubilized SV2H was immunoprecipitated from these pH-treated synaptosomes with either anti-SV1 (lanes 1a and 2c) or a control mAb (lanes 1b and 2d) . The immunoprecipitated SV2 was subjected to Western blot and probed with antilaminin-1 antibodies (Ln/Sppt).
Biotinylation of Synaptosomes Indicates That the 900-kDa Laminin Is a Major Component of the
tightly associated with SV2H on the synaptosomal surface. We alkaline-stripped synaptosomes with pH 11.5 as described above, biotinylated these membranes with sulfo-NHS-Biotin, and then immunoprecipitated Triton X-100 solubilized SV2H from the labeled membranes with anti-SV1 mAb. We used alkaline-stripped synaptosomes so that we would only detect proteins tightly bound to SV2H. However, the results are essentially the same if non-alkaline-stripped synaptosomes are used (data not shown). The immunoprecipitated proteins were subjected to SDS-PAGE under reducing conditions and electroblotted to nitrocellulose. We used sulfo-NHS-Biotin as a labeling reagent because we found that it reacts poorly with purified SV2 compared with other synaptic vesicle proteins (data not shown). It was important to minimize SV2 labeling so that co-immunoprecipitating proteins would not be obscured on nitrocellulose blots when stained for biotinylated proteins.
About 50% of the biotin label is present on the polypeptide chains derived from the ␣5 and ␤1 chains of the 900-kDa laminin. A major biotinylated polypeptide migrates at 230 kDa (Fig. 4, lane 1, arrowhead b) . When the blot is reprobed with anti-laminin 1, a 230-kDa polypeptide also stains (Fig. 4, lane  3) . This polypeptide is most likely the ␤1 chain for reasons detailed above. A biotinylated polypeptide is found migrating at 380 kDa (Fig. 4, lane 1, arrowhead a) . This polypeptide chain stains with the anti-␣5 antibody (Fig. 4, lane 3) and is about the molecular weight expected for the ␣5 chain (22) . In addition, we see several other biotinylated polypeptides that also stain with the anti-␣5 antibody (Fig. 4, lane 5) as follows: the major biotinylated protein migrating at 230 kDa (Fig. 4, lane 1, arrowhead b) and minor biotinylated proteins between 190 and 210 kDa (Fig. 5, lane 1, arrowhead c) and 170 kDa (Fig. 4, lane  1, arrowhead d) . These smaller polypeptides are quite likely fragments of the ␣5 chain that are held together by disulfide bonds in the intact unreduced protein. A similar pattern of fragmentation has been seen with laminin ␣5 chains from mouse lung and kidney tissue (22) . With these mouse tissues, Western blots probed with the same anti-␣5 antibodies reveal major polypeptides migrating at about 380 and about 210 kDa, like the major proteins seen here at 380 and 230 kDa. The finding that both anti-␣5 and anti-laminin-1 antibodies both identify a polypeptide at 230 kDa is probably due to co-migration of two polypeptides and not to cross-reactivity of the anti-␣5 antibody with the ␤1 chain. The anti-␣5 antibody shows no cross-reactivity with purified mouse laminin-1 chains (22) .
The anti-␣5 antibodies detect three polypeptides migrating between 550 and 650 kDa (Fig. 4, lane 5, asterisk) that are not labeled by biotin. These may be small amounts of partially reduced ␣5-containing laminin molecules lacking the antigenic region of the ␤1 chain.
There are five major co-immunoprecipitating biotinylated polypeptides that we have not identified (Fig. 4, lane 1, arrow heads e and f). Three polypeptides with molecular masses between 120 and 150 kDa (Fig. 4, lane 1, arrowhead e) together contain about 20% of the biotin label. These polypeptides might be related to the unidentified ␥ chain. Interestingly, the ␥2 chain made by rat and human cell lines has molecular a mass about 155 kDa (e.g. Ref. 47 ). The two polypeptides of 60 -66 kDa (Fig. 4, lane 1, arrowhead f) contain about 20% of the biotin label. The remaining 10% of the label is scattered among five very minor polypeptides that contain about 2% each.
Purified SV2H Binds Laminin-1-Since SV2H and the 900-kDa laminin are complexed together, it seemed possible that 125 I-SV2L (lane 2) by sedimentation velocity on sucrose gradients before SDS-PAGE (see "Experimental Procedures"). The arrow marks the beginning of the resolving gel. B, the lectin-bound SV2 contains the antigenicities expected for the H form; it was immunoprecipitated by both anti-SV1 (SV1) and anti-SV2 (SV2) mAbs (upper graph) but not by a control mAb (Ctl). SV2 that was not bound by tomato lectin (lower graph) behaved like the L form; it was not immunoprecipitated by anti-SV1 (SV1) mAb, only by the anti-SV2 mAb (SV2). they interact directly. Unfortunately, methods for purifying the 900-kDa Torpedo laminin are not yet available. However, laminin-1 contains ␣1, ␤1, and ␥1 chains. This laminin is similar to the 900-kDa laminin in that both contain the ␤1 chain, and the ␣5 chain has the same domain structure as the ␣1 chain (21) . Both chains contain domains I-VI as well as the G region. We reasoned that laminin-1 could contain a domain homologous to an SV2H-binding site on 900-kDa laminin. Although the domain could be tailored for another purpose, it might be similar enough to still bind SV2H. We therefore assayed binding between purified SV2H and commercially available laminin-1.
We developed a new procedure for the preparative purification of SV2H from synaptic vesicles. We first partially purified synaptic vesicles from electric organ homogenates following the methods of Carlson et al. (38) involving differential centrifugation and flotation equilibrium on sucrose density gradients. The synaptic vesicle proteins were solubilized with Triton X-100 and SV2 purified with the anti-SV2 mAb covalently linked to Affi-Gel-10. The SV2 was eluted from the antibody affinity column with a pH 11.5 solution, and the isolated proteoglycan was labeled with 125 I. To isolate the labeled SV2H from the L form, 125 I-SV2 was chromatographed on a tomato lectin-agarose column. By SDS-PAGE the flow-through contained the L form, a protein migrating at about 90 kDa (Fig. 5A,  lane 2) , whereas the H form bound the lectin column and was eluted by triacetylchitotriose (Fig. 5A, lane 1) . To confirm that H and L forms had been separated, we immunoprecipitated the 125 I-labeled SV2, which had bound the lectin column, and SV2, which had not. As expected, the SV2 that bound lectin was immunoprecipitated by both anti-SV1 and anti-SV2 mAbs (Fig.  5B , upper graph) indicating that it was the H form. The SV2 that had not bound lectin had the characteristics of the L form; it was immunoprecipitated only by the anti-SV2 mAb and not anti-SV1 (Fig. 5B, lower graph) .
The H form of SV2 as it elutes from the lectin column is at least 97% pure (Fig. 5A, lane 1) . We previously reported several unidentified proteins co-immunoprecipitating with SV2 from purified synaptic vesicles (2). However, we now believe that these were simply fragments of SV2, since they have been eliminated by controlling proteolysis.
To measure the binding between laminin-1 and SV2H, we used ACE. ACE is a gel retardation procedure (40) whereby the 125 I-SV2 H form is subjected to electrophoresis in the presence of laminin. An agarose gel is poured so that a lane containing 125 I-SV2H is positioned perpendicular to several lanes containing different concentrations of laminin-1 (Fig. 6A) . During electrophoresis, the front of 125 I-SV2H migrates through the laminin-containing lanes (Fig. 6B) . When the laminin concentration is above the dissociation constant (K d ) of the binding reaction between SV2H and laminin, the migration of SV2H in the agarose gel is retarded. If the laminin concentration is far below the dissociation constant, the SV2H migrates unimpeded. At intermediate concentrations of laminin, SV2H has intermediate mobilities (Fig. 6A) , quantitatively reflecting the amount of SV2H bound to laminin (40) .
The mobility of SV2H is greatly retarded on ACE at laminin-1 concentrations above about 100 nM (Fig. 6B) , indicating strong binding between laminin-1 and SV2H. In order to determine the dissociation constants (K d values) for laminin-1 binding to SV2H, we determined the distribution of 125 I-SV2H in the ACE gel lanes (for example, Fig. 6C, upper and lower  graphs) . Interestingly, at high concentrations of laminin-1 (e.g. Fig. 6C, lower graph) , we found a pattern suggesting that a subfraction of SV2H bound more tightly than the majority. In the absence of laminin-1, SV2H migrates as a single symmetrical peak of high mobility (Fig. 6C, upper graph) . In the presence of laminin-1, a slow migrating peak of SV2H (Fig. 6C , lower graph, labeled m 10% ) is seen superimposed on a larger distribution. This slowest moving peak (most tightly bound to laminin) migrates at 10% of the most retarded SV2H. Therefore, we determined m 10% which is the mobility or the distance migrated by the most retarded 10% of SV2H (Fig. 6C, lower  graph) . In addition, we also determined m 50% which is the distance migrated for the midpoint of the SV2H distribution (Fig. 6C, lower) . This latter mobility represents the average distance migrated for all of SV2H and is the standard measurement used by Lee and Lander (40) and San Antonio et al. (48) . From these types of measurements with five separate ACE gels (one of which is shown in Fig. 6B ), we calculated two retention coefficients (R 10% and R 50% ), where R ϭ (n Ϫ m)/n for The direction of the current flow is shown. At the end of the electrophoresis, a front of 125 I-SV2H has migrated through the laminin-containing lanes. If laminin binds SV2H, significant retardation of the SV2H mobility should occur in those lanes where the concentration of laminin is near the dissociation constant of the laminin⅐SV2H binding reaction. n is the distance traveled by SV2H in the absence of laminin; m is the distance traveled in the presence of laminin. B, a typical ACE gel for 125 I-SV2H and laminin-1. An autoradiograph of the gel is presented. The laminin-1 concentration is shown below each lane. "Or" marks the beginning of the laminin-containing lanes. C, a plot of the optical density versus distance migrated for SV2H at 0 nM laminin-1 (upper graph) and 183 nM laminin 1 (lower graph). These data were determined from the autoradiograph of the ACE gel in B. For each lane containing laminin two migration distances were determined by integrating the optical density versus migration distance curve as follows: m 10% for the most retarded 10% of the SV2H, and m 50% for the midpoint of the SV2H (lower graph). m 10% was chosen since it tracked the peak of the most retarded SV2H subfraction. For SV2H in the migrating in the absence of laminin, the corresponding migration distances, n 10% and n 50% were also determined (upper graph).
each laminin-1 concentration. A semilog plot of R 10% and R 50% versus laminin-1 concentration yields two sigmoidal curves ( . Thus, all SV2Hs forms bind laminin-1, but a high-affinity subfraction is probably present. In addition, no binding is seen between the SV2H form and BSA on ACE gels, and only weak binding (for R 10% , K d ϳ1 M) with another ECM protein, fibronectin.
DISCUSSION
Hypothesis, SV2H Binds the 900-kDa Laminin-We have shown that SV2H is associated with a 900-kDa laminin on synaptosomes isolated from electric organ. When solubilized in Triton X-100 from synaptosomes, these two proteins were found to co-immunoprecipitate. The association between these proteins is specific, since another laminin isoform on the synaptosome is not associated with SV2. Moreover, a presynaptic plasma membrane protein, the calcium channel, and a synaptic vesicle protein, synaptotagmin, are not part of the SV2H⅐900-kDa laminin complex. The interaction between SV2H and the 900-kDa laminin is strong in that it resists dissociation by pH 11.5, a condition that can solubilize peripheral membrane proteins. We find that the 900-kDa laminin is an ␣5␤1␥ trimer. Immunoprecipitation of the solubilized SV2H protein complex from biotinylated, alkaline-stripped synaptosomes reveals that the 900-kDa laminin is a major component of the complex.
We hypothesize that SV2H is binding directly to the ␣5␤1␥ trimer in the SV2H⅐laminin complex. This is based on the binding between pure laminin-1 and SV2H purified from synaptic vesicles. Laminin-1 is similar to the ␣5␤1␥ trimer in that both share the ␤1 chain, and the ␣1 chain has a very similar domain structure to the ␣5 chain. Presumably, laminin-1 contains an SV2H-binding site that is homologous, although not necessarily identical, to the SV2H-binding site on the ␣5␤1␥ trimer. Such a site is not present on all ECM molecules, since fibronectin shows very weak binding.
Characteristics of SV2H Binding to Laminin-1-Our finding of a higher affinity subfraction of SV2H for mouse laminin-1 suggests that the interaction might be mediated partially or completely by the keratan sulfate chains of SV2H. This observation is reminiscent of the binding of another glycosaminoglycan, heparin, to laminin-1. The g domains of the ␣1 chain are known to contain heparin-binding sites (20) . San Antonio et al. (48) have isolated two subfractions of heparin that bind laminin-1 with K d values of about 67 and 800 nM. The high affinity heparin subfraction is probably due to the presence of a particular oligosaccharide sequence or to a series of related sequences that are specifically recognized by a site on laminin-1 (48) . Although heparin is a polymerized disaccharide unit of uronic acid and N-acetylglucosamine, a specific sequence results from a particular set of modifications (especially sulfation) along the polysaccharide chain (49) . Likewise, keratan sulfate chains (polymerized galactose and n-acetylglucosamine) are known to be modified by sulfation, fucosylation, and sialylation (e.g. Ref. 50 ), which could result in high-affinity laminin-binding sites on a subfraction of SV2H keratan sulfate chains. Interestingly, the keratan sulfate chains of SV2 are known to be modified; they contain several unique keratan sulfate epitopes (2), one of which (1B4) is known to be the result of extensive sulfation (51) . Laminin-1 has not been tested for binding by free keratan sulfate chains.
Although the binding of SV2H to laminin-1 has some similarities to the binding of heparin, there is also an important difference. The subfraction of heparin that binds laminin-1 with a K d of 67 nM also binds the extracellular matrix protein, fibronectin, with a K d of 190 nM (48), a ratio of about 1:3. A subfraction of SV2H binds to laminin-1 with a K d of 68 nM and to fibronectin with a K d of 1000 nM, a ratio of about 1:15. Compared with fibronectin, SV2H has a greater specificity for laminin-1 than does heparin.
We attempted to test whether the keratan sulfate chains are involved in binding the ␣5␤1␥ laminin to SV2H by digestion of the complex with keratanase II and endo-␤-galactosidase. The integrity of the complex was unaffected by the digestion. However, this negative result does not rule out that the keratan sulfate chains mediate the interaction between ␣5␤1␥ laminin and SV2H. We found previously that the chains of SV2H are incompletely digested by keratanase I, or keratanase II, or endo-␤-galactosidase, or all three enzymes (2) . 3 Presumably some modification of the keratan sulfate chains makes them partially resistant to these enzymes.
Other Known Interactions of SV2H-Bennet et al. (53) proposed that synaptic vesicle proteins form a multimeric complex. When rat brain synaptic vesicles were solubilized in the detergent CHAPS, synaptophysin, SV2, synaptotagmin, VAMP, and the vacuolar H ϩ pump were found in a complex. This entire complex is probably loosely associated, since other non-denaturing detergents (e.g. Triton X-100 and octyl glucoside) partially dissolve it. The interaction between SV2 and synaptotagmin is most likely stronger, since these proteins remained associated after Triton X-100 solubilization. Schivell et al. (52) confirmed and extended this latter observation. They demonstrated that SV2 and synaptotagmin could be selectively crosslinked in intact membranes and further showed that the cytosolic N terminus of SV2A was binding the cytosolic C2B region of synaptotagmin. SV2⅐synaptotagmin complex is not. Bennet et al. (53) and Schivell et al. (52) found that the SV2⅐synaptotagmin complex was only immunoprecipitated by anti-synaptotagmin antibody. Since the anti-SV2 mAb immunoprecipitated only SV2 uncomplexed with synaptotagmin, Schivell et al. (52) proposed that the association between SV2 and synaptotagmin sterically hindered the anti-SV2 mAb from binding its antigenic site. Indeed, the SV2 epitope and the synaptotagmin-binding site are both in the N-terminal region (52) . Similarly, with Triton X-100-solubilized electric fish vesicles, we find no synaptotagmin immunoprecipitated by anti-SV2 mAbs (2). 2) Bennet et al. (53) and Schivell et al. (52) studied the interaction of SV2L with synaptotagmin and not SV2H, which we studied here. The SDS-PAGE system they employed (4 -12% gradient gels) does not allow for the detection of SV2H, since SV2H does not enter this resolving gel (2) . In fact, it is possible that SV2H does not interact with synaptotagmin. With the anti-SV1 mAb, we find no synaptotagmin co-immunoprecipitating with SV2H from Triton X-100-solubilized synaptosomes or synaptic vesicles ( Fig. 2A and Ref. 2) .
SV2H as a Laminin Receptor-Our finding that the SV2H⅐900-kDa laminin complex resists dissociation by pH 11.5 suggests that the binding between these proteins is of high affinity. However, the measured dissociation constant of 68 nM for SV2H and laminin-1 suggests a binding with moderate affinity. How might this apparent discrepancy be reconciled? One possibility is that the SV2H-binding site on the 900-kDa laminin is of much higher affinity than the homologous site on laminin-1. This might not be so surprising, since laminin-1 is not a synaptic laminin and the binding site might have a different purpose. Alternatively, the interaction between SV2H and the 900-kDa laminin in this protein complex might involve multipoint attachment, which would greatly increase the strength of the interaction. Such a possibility is similar to the binding of an IgG molecule that is 50 -100 times stronger with a bivalent antigen than with a monovalent antigen (54) . With a bivalent antigen both of the IgG-binding sites are attached to the same antigen molecule; with monovalent antigen only one is attached. In an analogous manner two linked SV2H proteins might bind two associated ␣5␤1␥ trimers (Fig. 8B) . Alternatively, SV2H might be associated with another transmembrane protein in the protein complex which also binds the 900-kDa laminin (Fig. 8C) .
Our discovery that SV2H and the 900-kDa laminin are associated on the synaptosomal surface suggests the following scenario (Fig. 8) . In synaptic vesicles SV2H is not complexed with laminin. However, once this membrane protein becomes incorporated into the nerve terminal plasma membrane due to exocytosis from the release of neurotransmitter, SV2H has the opportunity to bind the 900-kDa laminin of the synaptic basal lamina. If the extracellular domain of SV2H does not encounter laminin, then it would follow the known path of the other synaptic vesicle proteins. SV2 would enter a coated pit, undergo endocytosis, and become reincorporated into synaptic vesicles. If SV2H does bind laminin, it would form a linkage between the presynaptic membrane and the extracellular matrix. A cytosolic domain of SV2H could serve as an anchor for the nerve terminal cytoskeleton.
This hypothesis has several interesting implications as follows. 1) Work at the neuromuscular junction suggests that during nerve regeneration after injury, a basal lamina component acts as a cue for the placement of exocytotic machinery for neurotransmitter release by the returning axon (17) . A synaptic vesicle transmembrane protein like SV2H would be inserted into the presynaptic membrane in an ideal position to link the exocytotic machinery to an ECM cue. 2) This hypothesis suggests an activity-dependent mechanism for synaptic adhesion.
The more neurotransmitter that is released, the more SV2H that cycles through the presynaptic plasma membrane, and the greater the chance that SV2H will encounter and bind laminin in the basal lamina. Activity-dependent synaptic adhesion could be important in a process like synaptic competition (55) . FIG. 8 . Hypothesis: SV2H is a laminin receptor. We propose that SV2H in the presynaptic plasma membrane is a receptor for a 900-kDa laminin embedded in the synaptic extracellular matrix. Unbound SV2H is delivered to the presynaptic plasma membrane by fusion of the synaptic vesicle membrane during neurotransmitter release. Once SV2H is free to diffuse in this membrane, it could encounter an unoccupied laminin binding site and bind. Alternatively it could enter a coated pit, undergo endocytosis, and become reincorporated into synaptic vesicles. Given that the majority of the SV2H is present in synaptic vesicles in the nerve terminal, most of the time SV2H follows this latter route. The SV2H which binds laminin forms a linkage between the nerve terminal and synaptic ECM. We would expect that a cytosolic domain of SV2H would act as a cytoplasmic anchor for the nerve terminal cytoskeleton. In the model we show SV2H molecules associating with laminin in three possible ways: A, as a monomer, B, as a homodimer, and C, as a heterodimer. SV2H may have two functions in the nerve terminal: to act as a laminin receptor on the nerve terminal surface and to have an as yet undetermined function in the synaptic vesicle. Alternatively, synaptic vesicles may simply act as vehicles to place SV2H in the active zone of the presynaptic plasma membrane, where it can bind laminin and act as an anchor for the nerve terminal.
